NRC vs. GB, UPBD, NEO, DFIN, VVX, TASK, EVH, NVEE, PSFE, and OLO
Should you be buying National Research stock or one of its competitors? The main competitors of National Research include Global Blue Group (GB), Upbound Group (UPBD), NeoGenomics (NEO), Donnelley Financial Solutions (DFIN), V2X (VVX), TaskUs (TASK), Evolent Health (EVH), NV5 Global (NVEE), Paysafe (PSFE), and OLO (OLO). These companies are all part of the "business services" industry.
National Research vs.
Global Blue Group (NYSE:GB) and National Research (NASDAQ:NRC) are both small-cap business services companies, but which is the better business? We will contrast the two businesses based on the strength of their community ranking, media sentiment, analyst recommendations, profitability, valuation, institutional ownership, dividends, risk and earnings.
89.7% of Global Blue Group shares are held by institutional investors. Comparatively, 47.3% of National Research shares are held by institutional investors. 5.2% of Global Blue Group shares are held by company insiders. Comparatively, 2.0% of National Research shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Global Blue Group presently has a consensus target price of $6.00, suggesting a potential downside of 18.14%. Given Global Blue Group's stronger consensus rating and higher possible upside, equities research analysts clearly believe Global Blue Group is more favorable than National Research.
Global Blue Group has a beta of 0.41, meaning that its stock price is 59% less volatile than the S&P 500. Comparatively, National Research has a beta of 0.53, meaning that its stock price is 47% less volatile than the S&P 500.
National Research has a net margin of 17.32% compared to Global Blue Group's net margin of 10.29%. National Research's return on equity of 66.52% beat Global Blue Group's return on equity.
National Research received 108 more outperform votes than Global Blue Group when rated by MarketBeat users. However, 75.00% of users gave Global Blue Group an outperform vote while only 61.67% of users gave National Research an outperform vote.
National Research has lower revenue, but higher earnings than Global Blue Group. National Research is trading at a lower price-to-earnings ratio than Global Blue Group, indicating that it is currently the more affordable of the two stocks.
In the previous week, Global Blue Group had 10 more articles in the media than National Research. MarketBeat recorded 15 mentions for Global Blue Group and 5 mentions for National Research. National Research's average media sentiment score of 0.40 beat Global Blue Group's score of -0.15 indicating that National Research is being referred to more favorably in the news media.
Summary
Global Blue Group beats National Research on 9 of the 17 factors compared between the two stocks.
Get National Research News Delivered to You Automatically
Sign up to receive the latest news and ratings for NRC and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
National Research Competitors List
Related Companies and Tools
This page (NASDAQ:NRC) was last updated on 3/4/2025 by MarketBeat.com Staff
